QMGS的变化率预测了肌痛性骨髓质疏松症的甲状腺切除术后的复发情况
Xinxin Liu1, Ran Li1, Wenwen Li1
1Department of Neurology, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China.
概括
甲状腺切除术后质量肌痛严重症得分 (QMGS) 的低降低率预测了肌痛严重症 (MG) 的早期复发. 这一分数可以帮助识别患有术后复发风险较高的患者.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 手术研究的研究.
背景情况:
- 骨髓灰质炎 (MG) 是一种影响神经肌肉结合的自身免疫性疾病.
- 胸膜切除术是非胸膜性MG的治疗选择之一.
- 预测术后复发对于患者管理至关重要.
研究的目的:
- 评估在肌肉切除术后的定量性肌肉切除症严重得分 (QMGS) 的短期变化与在没有胸腺瘤的MG患者中随后的复发之间的关系.
- 确定QMGS减少率 (rr-QMGS) 作为复发的预测标记.
主要方法:
- 追溯观察队列研究44个非胸腺瘤性MG患者.
- QMGS评估了胸膜切除术前和1个月后的情况.
- 计算了QMGS (rr-QMGS) 的降低率.
- 接收器操作特征 (ROC) 曲线分析以确定 rr-QMGS 切线.
- 多变量考克斯回归和卡普兰-梅尔分析用于复发预测.
主要成果:
- 术后复发发生在21名患者中 (总共30次).
- 预测复发的rr-QMGS切线为36.7% (灵敏度为90.5%,特异性为52.2%).
- 低rr-QMGS (<36.7%) 是复发的一个显著预测因素 (HR 6.251,P=0.014).
- 在低rr-QMGS组 (12.62与36.60个月) 中观察到较早的复发.
结论:
- 胸膜切除术后QMGS的低降低率与非胸膜性MG的早期术后复发有关.
- 在这些患者中,Rr-QMGS作为预测术后复发的有价值工具.
相关概念视频
Myasthenia Gravis: Overview and Treatment
1.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.4K
Myasthenia Gravis: Diagnostic Tests
810
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
810


